An acetylated lysine residue of its low-glucose inhibitory domain controls activity and protein interactions of ChREBP

Tools

Item Type:	Article
Title:	An acetylated lysine residue of its low-glucose inhibitory domain controls activity and protein interactions of ChREBP
Creators Name:	Petricek, K.M., Kirchner, M., Sommerfeld, M., Stephanowitz, H., Kiefer, M.F., Meng, Y., Dittrich, S., Dähnhardt, H.E., Mai, K., Krause, E., Mertins, P., Wowro, S.J. and Schupp, M.
Abstract:	Carbohydrate response element-binding protein (ChREBP) is a transcription factor activated by glucose metabolites that orchestrates the expression of genes involved in glycolysis, de novo lipogenesis, and ATP homeostasis. Inadequate ChREBP activity impairs the cellular adaptations to glucose exposure and in humans associates with dyslipidemia, fatty liver disease, and type 2 diabetes. ChREBP activity is regulated by cytosolic-nuclear translocation involving its low-glucose inhibitory domain (LID). Whether this domain is targeted by post-translational lysine acetylation is unknown. Here we report a novel LID acetylation site that controls activity and protein interactions of ChREBP. Mutation of this residue increased glucose-induced activity and target gene expression of ChREBP. Mechanistically, mutant ChREBP protein showed more nuclear localization and enhanced genomic binding to a target promoter. Interactions with proteins that exhibit differential binding upon glucose exposure were attenuated by the mutation, demonstrating the importance of the LID in the formation of the protein interactome. Particularly interactions with 14-3-3 proteins, factors that regulate cytosolic/nuclear trafficking of ChREBP, were reduced, whereas interactions with proteins of the nucleosome remodeling deacetylase complex (NuRD) were increased. These molecular insights may shape new therapeutic strategies to target ChREBP activity and counteract metabolic diseases.
Keywords:	ChREBP, Glucose Sensing, Post-Translational Modification, Acetylation, Protein Interactome
Source:	Journal of Molecular Biology
ISSN:	0022-2836
Publisher:	Elsevier
Page Range:	169189
Date:	6 May 2025
Official Publication:	https://doi.org/10.1016/j.jmb.2025.169189
PubMed:	View item in PubMed

Repository Staff Only: item control page